Chronic Viral Hepatitis (Unknown Type), Serum
Use
The Chronic Viral Hepatitis Profile is used for the diagnosis and evaluation of patients with symptoms of hepatitis lasting more than 6 months. It is particularly useful in distinguishing between chronic hepatitis B and C infections, helping to guide management and treatment decisions. This test measures various antibodies and antigens associated with hepatitis B and C to provide a comprehensive profile of the patient's serological status.
Special Instructions
Not provided.
Limitations
Assay performance characteristics have not been established for patients under 21 years, pregnant women, or immunocompromised populations. Grossly hemolyzed, icteric, lipemic specimens, or those with high biotin levels may produce unreliable results. Transplacental passage of maternal HCV IgG can cause false-reactive results in infants up to 18 months old. Moreover, biotin supplements may interfere with assay results.
FDA ApprovedNew York Approved
Methodology
Immunoassay (ECLIA)
Biomarkers
LOINC Codes
- 92889-5 - Chronic hepatitis diff Pnl SerPl
- 13952-7 - HBV core Ab SerPl Ql IA
- 10900-9 - HBV surface Ab Ser Ql IA
- 5193-8 - HBV surface Ab SerPl IA-aCnc
- 5196-1 - HBV surface Ag SerPl Ql IA
- 40726-2 - HCV IgG SerPl Ql IA
Result Turnaround Time
1-2 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
2.5 mL
Minimum Volume
1.8 mL
Container
Plastic vial
Collection Instructions
Centrifuge blood collection tube per manufacturer's instructions and aliquot serum into a plastic vial.
Patient Preparation
Patient should not take biotin-containing supplements for 24 hours before collection.
Causes for Rejection
Gross hemolysis, gross lipemia, gross icterus, or heat-inactivated specimen.
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 6 days |
| Frozen | 84 days |